Whether you are in early-phase trials or ready for commercialization, Cognate is the right CDMO for your cell therapy products.
Cognate has experience in designing, building, implementing, and operating cGMP manufacturing infrastructure for autologous and allogeneic cell and cell-mediated therapy products in the US and abroad. When our current capacity does not meet the needs of your product or market, or you want to plan for a 2, 5, 10-or-more year commercial runway, we can work with you on a custom configuration in our available US expansion space, in an adjacent stand-alone facility, or in other geographies globally.
We can automate parts of your process including working with a 3rd party provider to create a modular fully-closed process that scales.
We offer a wide variety of services to ensure your clinical and/or commercial products are ready to meet patient demand.
Let’s talk about how our experience in manufacturing for pre-clinical trials through commercialization can transform your product goals.